2017-2025 World Biologics and Biosimilars Market Research Report (by Product Type, End-User/Application and Regions/Countries)
SUMMARY
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Biologics and Biosimilars , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Biologics and Biosimilars market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.
This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
The report includes as follows:
The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Biologics and Biosimilars , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Biologics and Biosimilars market prospects to 2025 are included (in sales, consumption and price).
Market Segment as follows:
By Region / Countries
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Russia, Spain etc)
- Asia-Pacific (China, India, Japan, Southeast Asia etc)
- South America (Brazil, Argentina etc)
- Middle East & Africa (Saudi Arabia, South Africa etc)
- Antibody
- Hormone
- Growth Factors
- Others
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Others
- Roche
- Amgen
- AbbVie
- Sanofi-Aventis
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Eli Lilly
- Novartis
- Merck
- 3sbio
- Changchun High Tech
- CP Guojian
- Biotech
- Gelgen
- Innovent
- Dong Bao
- Ganlee
- United Laboratories
1 MARKET DEFINITION
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application
2 GLOBAL MARKET BY VENDORS
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors
3 GLOBAL MARKET BY TYPE
3.1 Market Share
3.2 Introduction of End-Use by Different Products
4 GLOBAL MARKET BY END-USE / APPLICATION
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 GLOBAL MARKET BY REGIONS
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa
6 NORTH AMERICA MARKET
6.1 by Type
6.2 by End-Use / Application
6.3 by Regions
7 EUROPE MARKET
7.1 by Type
7.2 by End-Use / Application
7.3 by Regions
8 ASIA-PACIFIC MARKET
8.1 by Type
8.2 by End-Use / Application
8.3 by Regions
9 SOUTH AMERICA MARKET
9.1 by Type
9.2 by End-Use / Application
9.3 by Regions
10 MIDDLE EAST & AFRICA MARKET
10.1 by Type
10.2 by End-Use / Application
10.3 by Regions
11 MARKET FORECAST
11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
12 KEY MANUFACTURERS
12.EEW ENERGY FROM WASTE ROCHE
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Sales Revenue, Cost and Margin)
12.2 Amgen
12.3 AbbVie
12.4 Sanofi-Aventis
12.5 Johnson & Johnson
12.6 Pfizer
12.7 Novo Nordisk
12.8 Eli Lilly
12.9 Novartis
12.10 Merck
12.11 3sbio
12.12 Changchun High Tech
12.13 CP Guojian
12.14 Biotech
12.15 Gelgen
12.16 Innovent
12.17 Dong Bao
12.18 Ganlee
12.19 United Laboratories
13 PRICE OVERVIEW
13.1 Price Segment
13.2 Price Trend
14 RESEARCH CONCLUSION
1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application
2 GLOBAL MARKET BY VENDORS
2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors
3 GLOBAL MARKET BY TYPE
3.1 Market Share
3.2 Introduction of End-Use by Different Products
4 GLOBAL MARKET BY END-USE / APPLICATION
4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs
5 GLOBAL MARKET BY REGIONS
5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa
6 NORTH AMERICA MARKET
6.1 by Type
6.2 by End-Use / Application
6.3 by Regions
7 EUROPE MARKET
7.1 by Type
7.2 by End-Use / Application
7.3 by Regions
8 ASIA-PACIFIC MARKET
8.1 by Type
8.2 by End-Use / Application
8.3 by Regions
9 SOUTH AMERICA MARKET
9.1 by Type
9.2 by End-Use / Application
9.3 by Regions
10 MIDDLE EAST & AFRICA MARKET
10.1 by Type
10.2 by End-Use / Application
10.3 by Regions
11 MARKET FORECAST
11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)
12 KEY MANUFACTURERS
12.EEW ENERGY FROM WASTE ROCHE
12.1.2 Company Overview
12.1.2 Product and End-User / Application
12.1.3 Business Data (Sales Revenue, Cost and Margin)
12.2 Amgen
12.3 AbbVie
12.4 Sanofi-Aventis
12.5 Johnson & Johnson
12.6 Pfizer
12.7 Novo Nordisk
12.8 Eli Lilly
12.9 Novartis
12.10 Merck
12.11 3sbio
12.12 Changchun High Tech
12.13 CP Guojian
12.14 Biotech
12.15 Gelgen
12.16 Innovent
12.17 Dong Bao
12.18 Ganlee
12.19 United Laboratories
13 PRICE OVERVIEW
13.1 Price Segment
13.2 Price Trend
14 RESEARCH CONCLUSION
LIST OF TABLES
Table Global Biologics and Biosimilars Market and Growth by Type
Table Global Biologics and Biosimilars Market and Growth by End-Use / Application
Table Global Biologics and Biosimilars Revenue (Million USD) by Vendors (2017-2019)
Table Global Biologics and Biosimilars Revenue Share by Vendors (2017-2019)
Table Global Biologics and Biosimilars Market Volume () by Vendors (2017-2019)
Table Global Biologics and Biosimilars Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Biologics and Biosimilars Market (Million USD) by Type (2017-2019)
Table Global Biologics and Biosimilars Market Share by Type (2017-2019)
Table Global Biologics and Biosimilars Market Volume () by Type (2017-2019)
Table Global Biologics and Biosimilars Market Volume Share by Type (2017-2019)
Table Global Biologics and Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Global Biologics and Biosimilars Market Share by End-Use / Application (2017-2019)
Table Global Biologics and Biosimilars Market Volume () by End-Use / Application (2017-2019)
Table Global Biologics and Biosimilars Market Volume Share by End-Use / Application (2017-2019)
Table Global Biologics and Biosimilars Market (Million USD) by Regions (2017-2019)
Table Global Biologics and Biosimilars Market Share by Regions (2017-2019)
Table Global Biologics and Biosimilars Market Volume () by Regions (2017-2019)
Table Global Biologics and Biosimilars Market Volume Share by Regions (2017-2019)
Table North America Biologics and Biosimilars Market (Million USD) by Type (2017-2019)
Table North America Biologics and Biosimilars Market Share by Type (2017-2019)
Table North America Biologics and Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table North America Biologics and Biosimilars Market Share by End-Use / Application (2017-2019)
Table North America Biologics and Biosimilars Market (Million USD) by Regions (2017-2019)
Table North America Biologics and Biosimilars Market Share by Regions (2017-2019)
Table Europe Biologics and Biosimilars Market (Million USD) by Type (2017-2019)
Table Europe Biologics and Biosimilars Market Share by Type (2017-2019)
Table Europe Biologics and Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Biologics and Biosimilars Market Share by End-Use / Application (2017-2019)
Table Europe Biologics and Biosimilars Market (Million USD) by Regions (2017-2019)
Table Europe Biologics and Biosimilars Market Share by Regions (2017-2019)
Table Asia-Pacific Biologics and Biosimilars Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Biologics and Biosimilars Market Share by Type (2017-2019)
Table Asia-Pacific Biologics and Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Biologics and Biosimilars Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Biologics and Biosimilars Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Biologics and Biosimilars Market Share by Regions (2017-2019)
Table South America Biologics and Biosimilars Market (Million USD) by Type (2017-2019)
Table South America Biologics and Biosimilars Market Share by Type (2017-2019)
Table South America Biologics and Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table South America Biologics and Biosimilars Market Share by End-Use / Application (2017-2019)
Table South America Biologics and Biosimilars Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market Share by Regions (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market Share by Type (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market Share by Regions (2017-2019)
Table Global Biologics and Biosimilars Market (Million USD) Forecast by Regions (2020-2025)
Table Global Biologics and Biosimilars Market Share Forecast by Regions (2020-2025)
Table Global Biologics and Biosimilars Market Volume () Forecast by Regions (2020-2025)
Table Global Biologics and Biosimilars Market Volume Share Forecast by Regions (2020-2025)
Table Global Biologics and Biosimilars Market (Million USD) Forecast by Type (2020-2025)
Table Global Biologics and BiosimilarsMarket Share by Forecast Type (2020-2025)
Table Global Biologics and Biosimilars Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Biologics and Biosimilars Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Roche
Table Sales Revenue, Volume, Price, Cost and Margin of Amgen
Table Sales Revenue, Volume, Price, Cost and Margin of AbbVie
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi-Aventis
Table Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Merck
Table Sales Revenue, Volume, Price, Cost and Margin of 3sbio
Table Sales Revenue, Volume, Price, Cost and Margin of Changchun High Tech
Table Sales Revenue, Volume, Price, Cost and Margin of CP Guojian
Table Sales Revenue, Volume, Price, Cost and Margin of Biotech
Table Sales Revenue, Volume, Price, Cost and Margin of Gelgen
Table Sales Revenue, Volume, Price, Cost and Margin of Innovent
Table Sales Revenue, Volume, Price, Cost and Margin of Dong Bao
Table Sales Revenue, Volume, Price, Cost and Margin of Ganlee
Table Sales Revenue, Volume, Price, Cost and Margin of United Laboratories
Table Global Biologics and Biosimilars Market and Growth by Type
Table Global Biologics and Biosimilars Market and Growth by End-Use / Application
Table Global Biologics and Biosimilars Revenue (Million USD) by Vendors (2017-2019)
Table Global Biologics and Biosimilars Revenue Share by Vendors (2017-2019)
Table Global Biologics and Biosimilars Market Volume () by Vendors (2017-2019)
Table Global Biologics and Biosimilars Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Biologics and Biosimilars Market (Million USD) by Type (2017-2019)
Table Global Biologics and Biosimilars Market Share by Type (2017-2019)
Table Global Biologics and Biosimilars Market Volume () by Type (2017-2019)
Table Global Biologics and Biosimilars Market Volume Share by Type (2017-2019)
Table Global Biologics and Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Global Biologics and Biosimilars Market Share by End-Use / Application (2017-2019)
Table Global Biologics and Biosimilars Market Volume () by End-Use / Application (2017-2019)
Table Global Biologics and Biosimilars Market Volume Share by End-Use / Application (2017-2019)
Table Global Biologics and Biosimilars Market (Million USD) by Regions (2017-2019)
Table Global Biologics and Biosimilars Market Share by Regions (2017-2019)
Table Global Biologics and Biosimilars Market Volume () by Regions (2017-2019)
Table Global Biologics and Biosimilars Market Volume Share by Regions (2017-2019)
Table North America Biologics and Biosimilars Market (Million USD) by Type (2017-2019)
Table North America Biologics and Biosimilars Market Share by Type (2017-2019)
Table North America Biologics and Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table North America Biologics and Biosimilars Market Share by End-Use / Application (2017-2019)
Table North America Biologics and Biosimilars Market (Million USD) by Regions (2017-2019)
Table North America Biologics and Biosimilars Market Share by Regions (2017-2019)
Table Europe Biologics and Biosimilars Market (Million USD) by Type (2017-2019)
Table Europe Biologics and Biosimilars Market Share by Type (2017-2019)
Table Europe Biologics and Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Biologics and Biosimilars Market Share by End-Use / Application (2017-2019)
Table Europe Biologics and Biosimilars Market (Million USD) by Regions (2017-2019)
Table Europe Biologics and Biosimilars Market Share by Regions (2017-2019)
Table Asia-Pacific Biologics and Biosimilars Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Biologics and Biosimilars Market Share by Type (2017-2019)
Table Asia-Pacific Biologics and Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Biologics and Biosimilars Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Biologics and Biosimilars Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Biologics and Biosimilars Market Share by Regions (2017-2019)
Table South America Biologics and Biosimilars Market (Million USD) by Type (2017-2019)
Table South America Biologics and Biosimilars Market Share by Type (2017-2019)
Table South America Biologics and Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table South America Biologics and Biosimilars Market Share by End-Use / Application (2017-2019)
Table South America Biologics and Biosimilars Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market Share by Regions (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market Share by Type (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Biologics and Biosimilars Market Share by Regions (2017-2019)
Table Global Biologics and Biosimilars Market (Million USD) Forecast by Regions (2020-2025)
Table Global Biologics and Biosimilars Market Share Forecast by Regions (2020-2025)
Table Global Biologics and Biosimilars Market Volume () Forecast by Regions (2020-2025)
Table Global Biologics and Biosimilars Market Volume Share Forecast by Regions (2020-2025)
Table Global Biologics and Biosimilars Market (Million USD) Forecast by Type (2020-2025)
Table Global Biologics and BiosimilarsMarket Share by Forecast Type (2020-2025)
Table Global Biologics and Biosimilars Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Biologics and Biosimilars Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Roche
Table Sales Revenue, Volume, Price, Cost and Margin of Amgen
Table Sales Revenue, Volume, Price, Cost and Margin of AbbVie
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi-Aventis
Table Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk
Table Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Merck
Table Sales Revenue, Volume, Price, Cost and Margin of 3sbio
Table Sales Revenue, Volume, Price, Cost and Margin of Changchun High Tech
Table Sales Revenue, Volume, Price, Cost and Margin of CP Guojian
Table Sales Revenue, Volume, Price, Cost and Margin of Biotech
Table Sales Revenue, Volume, Price, Cost and Margin of Gelgen
Table Sales Revenue, Volume, Price, Cost and Margin of Innovent
Table Sales Revenue, Volume, Price, Cost and Margin of Dong Bao
Table Sales Revenue, Volume, Price, Cost and Margin of Ganlee
Table Sales Revenue, Volume, Price, Cost and Margin of United Laboratories
LIST OF FIGURES
Figure Global Biologics and Biosimilars Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Biologics and Biosimilars Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Biologics and Biosimilars Market Volume () and Growth Forecast (2020-2025)
Figure Global Biologics and Biosimilars Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Biologics and Biosimilars Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Biologics and Biosimilars Market Volume () and Growth Forecast (2020-2025)
